serotonin 5HT2A/ 2C, 5HT3, 5HT6, dopamin D1, D2, D3, D4, D5, cholinergní muskarinové receptory (m1- m5), alfa1 adrenergní a histaminové H1 receptory.
In preclinical studies, olanzapine exhibited a range of receptor affinities (Ki; < 100 nM) for serotonin 5 HT2A/ 2C, 5 HT3, 5 HT6; dopamine D1, D2, D3, D4, D5; cholinergic muscarinic receptors m1-m5; α adrenergic; and histamine H1 receptors.